Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Sumitomo claims compounds for treating reperfusion injury

March 18, 1998

Cardiovascular disease gene discovered

March 17, 1998

Glaxo Wellcome, Boehringer Ingelheim collaborate to bring telmisartan to market

March 16, 1998

Yamanouchi investigates orally active AII antagonists

March 13, 1998

Vasopressin antagonists for treating CHF

March 12, 1998

Diovan HCT approved in U.S.

March 11, 1998

Inex finalizes acquisition of Lynx antisense assets

March 11, 1998

FDA advisory panel to review TMR using Heart Laser System

March 11, 1998

The effects of NPY antagonist BIBP-3226 on blood pressure and heart rate

March 11, 1998

UT-15 will move to phase III for pulmonary hypertension

March 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.